Lisa Prussick is a Dermatology physician affiliated with Tufts University. OpenAlex indexes 17 publications with 378 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20232 payments
- Galderma Laboratories, L.P.Program year20231 payment
- Galderma Laboratories, L.P.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
31.1%Corticosteroid18.3%Triamcinolone Acetonide100%Part D≥22 patientsInterleukin-4 Receptor alpha Antagonist12.8%Dupixent Syringe100%Part D<11 patientsSensory organs
26.8%Corticosteroid26.8%Clobetasol Propionate50%Betamethasone Dipropionate25%Hydrocortisone25%Part D<11 patientsAnti-infectives
19.5%Azole Antifungal19.5%Ketoconazole100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Leukocytoclastic vasculitis flare following the COVID‐19 vaccine
International Journal of Dermatology
2021 - Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial
Journal of the American Academy of Dermatology
2020 - A Review of Treatments for Dissecting Cellulitis of the Scalp
SKIN The Journal of Cutaneous Medicine
2019
Similar KOLs
Other experts from the same institution or the same specialty.
David Snydman, MD
Tufts University
Gitanjali M Singh
Tufts University
Richard Karas, MD
Tufts University
Raymond Comenzo, MD
Tufts University
Bridget Grant, MD
Bassett Medical Center
Robert Modlin, MD
University of California, Los Angeles
Andrew Blauvelt, MD
University of Maryland School of Medicine
Howard Maibach, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”